195 related articles for article (PubMed ID: 16493875)
1. [1+1 or 2x1? Another form of dual antidepressive mechanism of action].
Lakatos L; Rihmer Z
Neuropsychopharmacol Hung; 2005 Sep; 7(3):118-24. PubMed ID: 16493875
[TBL] [Abstract][Full Text] [Related]
2. Designing a new generation of antidepressant drugs.
Pinder RM
Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
[TBL] [Abstract][Full Text] [Related]
3. Development of new antidepressants.
Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
5. Do some antidepressants work faster than others?
Nierenberg AA
J Clin Psychiatry; 2001; 62 Suppl 15():22-5. PubMed ID: 11444763
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?
Schreiber S; Bleich A; Pick CG
J Mol Neurosci; 2002; 18(1-2):143-9. PubMed ID: 11931344
[TBL] [Abstract][Full Text] [Related]
7. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
[TBL] [Abstract][Full Text] [Related]
8. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
Jaracz J; Rybakowski J
Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
[TBL] [Abstract][Full Text] [Related]
9. [Review of antidepressants from the TCAs to the third generation drugs].
Almási J; Rihmer Z
Neuropsychopharmacol Hung; 2004 Dec; 6(4):185-94. PubMed ID: 15825674
[TBL] [Abstract][Full Text] [Related]
10. An overview of the clinical efficacy of mirtazapine.
Benkert O; Muller M; Szegedi A
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine: clinical overview.
Gorman JM
J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
[TBL] [Abstract][Full Text] [Related]
12. Dual action antidepressants and some important considerations.
Gupta RK; Tiller JW; Burrows GD
Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
[TBL] [Abstract][Full Text] [Related]
13. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
14. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
[TBL] [Abstract][Full Text] [Related]
15. New formulations of existing antidepressants: advantages in the management of depression.
Norman TR; Olver JS
CNS Drugs; 2004; 18(8):505-20. PubMed ID: 15182220
[TBL] [Abstract][Full Text] [Related]
16. Optimizing antidepressant treatment: efficacy and tolerability.
Deakin B; Dursun S
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine versus other antidepressive agents for depression.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2011 Dec; (12):CD006528. PubMed ID: 22161405
[TBL] [Abstract][Full Text] [Related]
18. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Al-Adwani A
Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
[No Abstract] [Full Text] [Related]
19. Mechanism of action of antidepressants.
Artigas F; Nutt DJ; Shelton R
Psychopharmacol Bull; 2002; 36 Suppl 2():123-32. PubMed ID: 12490828
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
Llorca PM; Fernandez JL
Int J Clin Pract; 2007 Apr; 61(4):702-10. PubMed ID: 17394446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
